TCG Crossover Management, LLC

PALO ALTO, CA · Quarter end: Sep 30, 2026 · Filed with SEC: Nov 16, 2026 · Open the SEC source ↗
Portfolio Return (1Y)——
Portfolio Value (AUM)Total value of the fund's US stock portfolio reported to the SEC.$3.54B2026 Q3
Positions57
Top-10 ConcentrationPercent of the portfolio in the 10 largest holdings. High means the fund is concentrated in few stocks.53.3%

TCG Crossover Management, LLC reported 57 positions worth $3.54B as of September 30, 2026 (13F filed November 16, 2026). Largest holding: ABVX (10.2%). Biggest move: reduce ABVX ($232.2M).

10 / 57 positions shown
#SymbolCompanyValue ↓% Port.Shares1YYTDSince reported
▸ 1 ABVXAbivax S.A.$362.7M10.25%3,663,038———
▸ 2 CGONCG Oncology$260.2M7.35%3,670,206——+5.0%
▸ 3 AMLXAmylyx Pharmaceuticals$181.7M5.13%6,243,812——-4.5%
▸ 4 SYRESpyre Therapeutics$169.2M4.78%1,900,582——+16.8%
▸ 5 TNGXTango Therapeutics$169.0M4.77%6,773,043——-3.1%
▸ 6 ZLABZai Lab$164.1M4.64%6,229,081——-10.9%
▸ 7 IMVTImmunovant$150.6M4.25%4,457,988——-1.5%
▸ 8 DNTHDianthus Therapeutics$147.6M4.17%1,676,624——+1.7%
▸ 9 KRSAKorsana Biosciences$145.6M4.11%4,549,587———
▸ 10 KODKodiak Sciences$137.0M3.87%1,445,538——+6.3%

Pro Feature

The remaining 47 positions with Pro.

Upgrade to Pro

Read the 2026-Q2 quarterly report · 13F Filing Calendar

🔔 Tell me when this fund files a new 13F

No account needed: in your inbox the morning it is published.

Frequently Asked Questions

What stocks does TCG Crossover Management, LLC hold as of Q3 2026?

TCG Crossover Management, LLC reported 57 positions worth $3.54B in its Q3 2026 13F filing. Largest positions: ABVX (10.2%), CGON (7.4%), AMLX (5.1%), SYRE (4.8%) and TNGX (4.8%).

What did TCG Crossover Management, LLC buy in Q3 2026?

New positions: KRSA, ADRX, ENTERA BIO LTD, TARS and OBX (8 in all). Added to: TYRA, MIRM, AURA and ZLAB.

What did TCG Crossover Management, LLC sell in Q3 2026?

Reduced: ABVX, COGT, TNGX, LBRX and SLN (15 in all). Sold out entirely: RVMD, SRZN, ALT, FBRXGBP and RACC.

13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.